Epilepsy, Tonic-clonic — Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
Citation(s)
A Multicenter, Double-blind, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) and Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Coming From the N01061 Trial.